Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RadNet CEO Howard Berger

RadNet’s PET/CT volume jumps 17%, with imaging backlogs in many of its markets

Meanwhile, MRI and CT volumes both increased nearly 10% in Q3 when compared to the same period in 2023, the Los Angeles-based company reported.

cardiologist salary and compensation data

Private equity transactions in healthcare down 15% since 2023, report finds

However, an analysis from research firm PitchBook suggests a rebound could be on the horizon, as investors shift their gaze to specialty care services. 

money maze benjamin franklin reimbursement medicare

Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

value quality value-based care

Effort to stop primary care providers from ordering low-value imaging hits brick wall

Researchers with the University of California, Davis, detailed their randomized clinical trial in JAMA Network Open Wednesday. 

Bracco

Bracco invests nearly $86M to more than triple production of key imaging agent

The Italy-based company is working to erect a new facility in Switzerland focused on its contrast-enhanced ultrasound products. 

Thumbnail

Looming fear of more IV shortages as Hurricane Rafael gains strength

The IV solution supply chain is still recovering after Hurricane Helene damaged a manufacturing site in North Carolina. 

Renal denervation systems from Recor Medical, Medtronic receive new outpatient payments

Both FDA-approved systems previously received inpatient payments in August. 

Walgreens settles class-action fraud lawsuit for $100M

The pharmacy chain is accused of charging insurance more for generic drugs than uninsured customers of its Prescription Saving Club.